Microcystic adnexal carcinoma: treatment with Mohs micrographic surgery.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 15692477.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Microcystic adnexal carcinoma (MAC) is reported to have a high rate of recurrence with standard wide local excision. To report a large series of patients with MAC treated with Mohs micrographic surgery (MMS). This prospective, multi-center case series included all patients in Australia treated with MMS for MAC, who were monitored by the Skin and Cancer Foundation between 1993 and 2002. There were 44 cases; most of them (90.9%) were located in the head and neck area. In 31.8% of cases it was a recurrent tumor. In 32.5% of cases the tumor was initially misdiagnosed as basal cell carcinoma or squamous cell carcinoma. Perineural invasion was recorded in 17.5% of cases; most of them (85.7%) were previously recurrent tumors. There was only one case of recurrence (5%) out of 20 patients who completed a 5 year follow-up period after MMS. The low 5-year recurrence rate of MAC with MMS emphasizes the importance of margin-controlled excision.
Medical subject headings
- Carcinoma, Skin Appendage
- Mohs Surgery
- Skin Neoplasms